Presentations at Two Upcoming Oncology Conferences to Highlight Benefits of Champions Oncology TumorGrafts

Hackensack, NJ – October 16, 2014 – Champions Oncology (CSBR) a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that Champions TumorGrafts® are the subject of presentations at the Connective Tissue Oncology Society Annual Meeting and the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.

Connective Tissue Oncology Society Annual Meeting (October 15-18, Berlin)

Title : Individualizing Therapeutic Approaches : The Use of Patient-Derived Xenograft (PDX) Models to Predict Patient Response to Therapy in Pediatric Sarcoma
Abstract : 2048726

Title : A Prospective Correlative Trial of Personalized Patient-Derived Xenograft (PDX) Modeling in Patients with Metastatic or Recurrent Sarcoma : Study Design and Rationale
Abstract : 2048742

Presentation Date/Time : October 16, 5:30 p.m. CEST
Location : InterContinental Berlin Hotel, Potsdam II & IV

2014 Chicago Multidisciplinary Symposium in Thoracic Oncology (October 30-November 1, Chicago)

Title : The Use Of Patient-derived Xenograft (PDX) Models To Predict Patient Response In Non-small Cell Lung Cancer (NSCLC)
Abstract : 3332

Presentation Date/Time : October 30, 5:00 p.m. CDT
Location : Chicago Marriott Downtown Magnificent Mile